These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7974621)

  • 21. Stimulant and relaxant drugs combined with stimulant and relaxant information: a study of active placebo.
    Flaten MA; Simonsen T; Zahlsen K; Aamo T; Sager G; Olsen H
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):426-34. PubMed ID: 15549277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carisoprodol, meprobamate, and driving impairment.
    Logan BK; Case GA; Gordon AM
    J Forensic Sci; 2000 May; 45(3):619-23. PubMed ID: 10855968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carisoprodol - Effects on Human Performance and Behavior.
    Robertson MM; Marinetti LJ
    Forensic Sci Rev; 2003 Jan; 15(1):1-9. PubMed ID: 26256591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid quantitative method of carisoprodol and meprobamate by liquid chromatography-tandem mass spectrometry.
    Essler S; Bruns K; Frontz M; McCutcheon JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():155-60. PubMed ID: 23040985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of carisoprodol and meprobamate in whole blood using benzylcarbamate and deuterated meprobamate as internal standards.
    Downey D; Simons K; Ota K; Kerrigan S
    J Anal Toxicol; 2009 Jun; 33(5):278-82. PubMed ID: 19671248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of carisoprodol and acetaminophen in an attempted suicide by liquid chromatography-mass spectrometry with positive electrospray ionization.
    Matsumoto T; Sano T; Matsuoka T; Aoki M; Maeno Y; Nagao M
    J Anal Toxicol; 2003 Mar; 27(2):118-22. PubMed ID: 12670008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-related information generates placebo and nocebo responses that modify the drug response.
    Flaten MA; Simonsen T; Olsen H
    Psychosom Med; 1999; 61(2):250-5. PubMed ID: 10204979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.
    Kumar M; Dillon GH
    Eur J Pharmacol; 2016 Mar; 775():149-58. PubMed ID: 26872987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FIXED DRUG ERUPTION CROSS REACTION OF MEPROBAMATE AND CARISOPRODOL.
    GORE HC
    Arch Dermatol; 1965 Jun; 91():627. PubMed ID: 14298818
    [No Abstract]   [Full Text] [Related]  

  • 31. Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.
    Høiseth G; Bramness JG; Christophersen AS; Mørland J
    Int J Legal Med; 2007 Sep; 121(5):403-9. PubMed ID: 17115170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometric analysis of carisoprodol and meprobamate in rat brain microdialysates.
    Prokai L; Fryčák P; Nguyen V; Forster MJ
    J Mass Spectrom; 2016 Oct; 51(10):900-907. PubMed ID: 27747995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carisoprodol: update on abuse potential and legal status.
    Reeves RR; Burke RS; Kose S
    South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meprobamate dependence secondary to carisoprodol (Soma) use.
    Littrell RA; Sage T; Miller W
    Am J Drug Alcohol Abuse; 1993; 19(1):133-4. PubMed ID: 8438828
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem.
    Lu A; Scott KS; Chan-Hosokawa A; Logan BK
    J Anal Toxicol; 2017 Mar; 41(2):134-139. PubMed ID: 27798072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed drug eruption to carisoprodol and cross reaction with meprobamate.
    HONEYCUTT WM; CURTIS AC
    JAMA; 1962 May; 180():691-2. PubMed ID: 13908692
    [No Abstract]   [Full Text] [Related]  

  • 37. Carisoprodol: a drug of continuing abuse.
    Reeves RR; Pinkofsky HB; Carter OS
    J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug.
    Høiseth G; Karinen R; Sørlid HK; Bramness JG
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):345-9. PubMed ID: 19663822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carisoprodol withdrawal after internet purchase.
    Eleid MF; Krahn LE; Agrwal N; Goodman BP
    Neurologist; 2010 Jul; 16(4):262-4. PubMed ID: 20592570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of carisoprodol and meprobamate in human hair using solid-phase extraction and gas chromatography/mass spectrometry of the trimethylsilyl derivatives.
    Kim JY; In MK; Paeng KJ; Chung BC
    Rapid Commun Mass Spectrom; 2005; 19(21):3056-62. PubMed ID: 16200657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.